Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.19.1
Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Product revenue $ 0 $ 0
Cost of product revenue 0 0
Gross profit 0 0
Operating expenses:    
Research and development 218,216 94,544
General and administrative 468,390 882,099
Total operating expenses 686,606 976,643
Loss from continuing operations before interest (686,606) (976,643)
Interest (income) expense, net 7,118 (1,315)
Loss from continuing operations (693,724) (975,328)
Loss from discontinued operations (347,175) (1,080,834)
Net loss $ (1,040,899) $ (2,056,162)
Loss from continuing operations per share – basic and fully diluted $ (0.05) $ (0.07)
Loss from discontinued operations per share – basic and fully diluted (0.02) (0.08)
Net loss per share – basic and fully diluted $ (0.07) $ (0.15)
Weighted average number of shares outstanding – basic and fully diluted 14,313,525 13,991,121